SPONSOR
Shengjing Hospital
Total Trials
8
Recruiting
8
Phases
Phase 4
Conditions studied: Chronic Kidney Disease (CKD)Pulmonary Embolism and ThrombosisDeterioration, ClinicalArtificial IntelligenceMetastatic Colorectal CancerBreast CancerTwin; Complicating PregnancyPsychology
Shengjing Hospital is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Chronic Kidney Disease (CKD), Pulmonary Embolism and Thrombosis, Deterioration, Clinical, Artificial Intelligence.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shengjing Hospital
How many clinical trials has Shengjing Hospital sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Shengjing Hospital, of which 8 are actively recruiting participants. These trials cover conditions including Chronic Kidney Disease (CKD), Pulmonary Embolism and Thrombosis, Deterioration, Clinical. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shengjing Hospital research focus on?
Shengjing Hospital clinical trials span Chronic Kidney Disease (CKD), Pulmonary Embolism and Thrombosis, Deterioration, Clinical, Artificial Intelligence, Metastatic Colorectal Cancer, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shengjing Hospital clinical trial?
To participate in a Shengjing Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shengjing Hospital trials with current recruitment status updated daily.
Clinical Trials by Shengjing Hospital
NCT06202235
Recruiting
Multifrequency MRE in Evaluation of Chronic Kidney Diseases
Chronic Kidney Disease (CKD)
NCT05482269
Recruiting
Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
Pulmonary Embolism and Thrombosis
NCT06208397
Recruiting
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
Metastatic Colorectal Cancer
NCT05263570
Recruiting
The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.
Breast Cancer
NCT05182541
Recruiting
Psychological Screening and Nursing of Twin Pregnancy
Twin; Complicating Pregnancy
NCT06698679
Recruiting
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
Breast Cancer
NCT04136782 Phase 4
Recruiting
Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer
Breast Cancer
NCT05241119
Recruiting
Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology